Skip to content

Sweet taste perception in relation to mouth and intestinal microbiota in people with (risk of) Diabetes

Sweet taste perception in relation to mouth and intestinal microbiota in people with (risk of) Diabetes - Diabetes oral sensing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46352
Enrollment
100
Registered
2018-05-14
Start date
2018-06-27
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes T2D

Interventions

Phase I study: not applicable. Phase II study: steviol glycosides are administered to both groups.

Sponsors

TNO
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Able to speak, write and understand Dutch * Voluntary participation * Provided written informed consent * Willing to comply with the study procedures of phase 1 and phase 2 * Appropriate veins and circulation for blood sampling * Willing to accept use of all nameless data, including publication(s), and the confidential use and storage of all data for at least 15 years * Willing to accept the disclosures of the financial benefit of participation in the study to the authorities concerned

Exclusion criteria

Exclusion criteria: * Any significant medical reason for exclusion as determined by the investigator * Having a history of medical or surgical (gastrointestinal) events that may significantly affect the study outcome * Smoking * Other medication for diabetes than oral medication (i.e. Insulin) * Recent antibiotic medication (in the last 3 months) * Alcohol consumption > 21 units/week * Unable to give written informed consent * Not willing to give up blood donation during the study * Not having a general practitioner * Not willing to accept information transfer concerning participation in the study, or information regarding his health, like laboratory results, findings at anamnesis or physical examination and eventual adverse events to and from his general practitioner

Design outcomes

Primary

MeasureTime frame
Primary study parameters/endpoints: * Differences between control and diabetes patients in: o sweet detection threshold o composition and diversity of the oral and gut microbiota

Secondary

MeasureTime frame
Secondary study parameters/endpoints: * Differences between control and diabetes patients in: o metabolic response to sweet by the gut o the ways in which the above three parameters (sweet detection threshold, microbiota and metabolic response) relate to each other

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)